Troxerutin USP Grade from Japan
Troxerutin is a hydroxyethyl derivative of rutin (rutoside), semi-synthetically produced for enhanced bioavailability in vascular health supplements. Classified under HTS 2938.10.00.00 as a rutoside derivative glycoside, it complies with Chapter 29 provisions for chemically defined organic compounds and their ethers/esters. This fine powder meets USP standards for pharmaceutical use.
Duty Rate — Japan → United States
26%
Rate breakdown
9903.04.6213.5%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.4912.5%Except for products described in headings 9903.05.85–9903.05.92, articles the product of Japan, with an ad valorem (or ad valorem equivalent) rate of duty under column 1 less than 12.5 percent, as provided for in U.S. note 52 to this subchapter
Import Tips
• Provide pharmacopoeial certificates (USP/EP) confirming derivative status; ensure no added excipients to prevent heading 3824 reclassification
• Label clearly as 'not for retail' if bulk to comply with FDA import rules